• Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, P. R. China;
ZHANG Guangjian, Email: micheal8039@xjtu.edu.cn
Export PDF Favorites Scan Get Citation

From December 2022 to January 2023, 4 lung transplant recipients (3 males and 1 female, aged 52-60 years, all received transplantation less than 1 year) were hospitalized in the Department of Thoracic Surgery of the First Affiliated Hospital of Xi'an Jiaotong University due to COVID-19 after surgery. The clinical manifestations were mostly characterized by elevated body temperature accompanied by shortness of breath, and indicators such as heart rate, oxygen saturation, and oxygenation index could reflect the severity of the condition. The therapy was timely adjusted to immunosuppressive drugs, upgraded oxygen therapy, anti-bacterial and anti-fungal therapy, prone ventilation, general treatment, and anticoagulant therapy, depending on the situation. Finally, 3 patients were cured and discharged from hospital, and 1 died.

Citation: WANG Hongyi, LI Yixing, ZHAO Heng, ZHANG Yanpeng, GAO Shan, WANG Jizhao, ZHAO Yilong, LI Shuo, ZHANG Guangjian. COVID-19 after lung transplantation: Four case reports. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(11): 1697-1702. doi: 10.7507/1007-4848.202306010 Copy

  • Previous Article

    Left ventricular assist devices implantation via left antero-lateral thoracotomy: A case report